Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
BDTX Black Diamond Therapeutics
- 2.560
- +0.060+2.40%
Close Dec 13 16:00 ET
- 2.490
- -0.070-2.73%
Post 20:01 ET
144.86MMarket Cap-1.92P/E (TTM)
2.590High2.415Low729.34KVolume2.500Open2.500Pre Close1.83MTurnover1.85%Turnover RatioLossP/E (Static)56.59MShares7.66052wk High1.49P/B101.21MFloat Cap2.31052wk Low--Dividend TTM39.54MShs Float46.250Historical High--Div YieldTTM7.00%Amplitude1.180Historical Low2.510Avg Price1Lot Size
About Black Diamond Therapeutics Company
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Company Profile
SymbolBDTX
Company NameBlack Diamond Therapeutics
Listing DateJan 30, 2020
Issue Price19.00
Founded2014
CEODr. Mark A. Velleca, M.D.
MarketNASDAQ
Employees54
Fiscal Year Ends12-31
AddressOne Main Street,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-252-0848
Company Executives
- Name
- Position
- Salary
- Dr. Mark A. Velleca, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.95M
- Melanie Morrison
- Chief Development Officer
- --
- Elizabeth L. Montgomery
- Chief People Officer
- --
- Brent Hatzis-Schoch, Esq.
- Chief Operating Officer and General Counsel
- --
- Elizabeth Buck, PhD
- Chief Scientific Officer
- --
- Sergey Yurasov, M.D.,Pd.D
- Chief Medical Officer
- 1.23M
- Erika Jones
- Chief Financial Officer and Principal Accounting Officer
- --
- Shannon Campbell, PhD
- Independent Director
- --
- Dr. Garry E. Menzel, PhD
- Independent Director
- 75.35K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 68.14K
- Dr. Prakash Raman, PhD
- Independent Director
- --
- Dr. Samarth Kulkarni, PhD
- Lead Independent Director
- 59.35K
- Dr. Kapil Dhingra, M.B.B.S.
- Independent Director
- 109.35K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.